A Phase 3, Multi-regional, Open-label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide in Participants with Relapsed/Refractory Primary Central Nervous System Lymphoma"
Clinical Trial Grant
Awarded By
Deciphera Pharmaceuticals, LLC
Start Date
April 27, 2026
End Date
April 30, 2031
Awarded By
Deciphera Pharmaceuticals, LLC
Start Date
April 27, 2026
End Date
April 30, 2031